Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
TGA issues warning over GLP-1-based drugs' potential to cause rare eye disorder Fri 24 Jul 2026 at 11:13am In short: The Therapeutic Goods Administration is warning of a rare but serious eye disorder that could be caused by GLP-1-based drugs
The (Glu + Gly)/(Cit + Arg) ratio was appropriate to discriminate heterozygous female patients with ornithine transcarbamylase deficiency (OTCD) from others, and this disease is the most common urea cycle disorder [43]
Clinical qualification: folic acid remains important for preventing neural-tube defects
10.1111/j.1572-0241.2002.05914.x 115
US$ 20.29
US$ 21.06
US$ 29.78
US$ 21.64
US$ 20.92
